MONTELEONE, Palmiero
 Distribuzione geografica
Continente #
NA - Nord America 27.054
AS - Asia 11.847
EU - Europa 7.445
SA - Sud America 844
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 36
OC - Oceania 30
Totale 47.326
Nazione #
US - Stati Uniti d'America 26.896
HK - Hong Kong 5.531
UA - Ucraina 2.088
CN - Cina 2.086
SG - Singapore 1.814
IT - Italia 1.740
DE - Germania 863
VN - Vietnam 765
TR - Turchia 753
BR - Brasile 714
RU - Federazione Russa 643
IE - Irlanda 611
KR - Corea 487
SE - Svezia 471
FI - Finlandia 470
IN - India 200
GB - Regno Unito 117
FR - Francia 107
CA - Canada 80
AT - Austria 62
AR - Argentina 47
MX - Messico 41
JP - Giappone 38
PL - Polonia 36
EU - Europa 35
NL - Olanda 33
ES - Italia 32
EC - Ecuador 26
BD - Bangladesh 23
BE - Belgio 23
AU - Australia 21
IQ - Iraq 21
CZ - Repubblica Ceca 18
ID - Indonesia 15
RO - Romania 15
ZA - Sudafrica 15
BG - Bulgaria 14
CH - Svizzera 14
PE - Perù 13
UZ - Uzbekistan 13
VE - Venezuela 13
JO - Giordania 11
NP - Nepal 11
IL - Israele 10
EG - Egitto 9
LT - Lituania 9
NZ - Nuova Zelanda 9
AE - Emirati Arabi Uniti 8
HR - Croazia 8
HU - Ungheria 8
IR - Iran 8
PK - Pakistan 8
GR - Grecia 7
MA - Marocco 7
NO - Norvegia 7
PY - Paraguay 7
UY - Uruguay 7
CL - Cile 6
DO - Repubblica Dominicana 6
RS - Serbia 6
BN - Brunei Darussalam 5
BO - Bolivia 5
KE - Kenya 5
PT - Portogallo 5
SA - Arabia Saudita 5
AL - Albania 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
DZ - Algeria 4
ET - Etiopia 4
GT - Guatemala 4
LU - Lussemburgo 4
MD - Moldavia 4
MK - Macedonia 4
SN - Senegal 4
SV - El Salvador 4
CO - Colombia 3
GH - Ghana 3
IM - Isola di Man 3
JM - Giamaica 3
MN - Mongolia 3
MY - Malesia 3
PS - Palestinian Territory 3
TN - Tunisia 3
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GL - Groenlandia 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
LC - Santa Lucia 2
LI - Liechtenstein 2
LV - Lettonia 2
MC - Monaco 2
Totale 47.281
Città #
Ann Arbor 6.775
Hong Kong 5.520
Woodbridge 2.664
Jacksonville 2.555
Wilmington 2.306
Chandler 2.161
Princeton 1.910
Houston 1.708
Dallas 1.096
Ashburn 809
Izmir 728
Dong Ket 610
Dublin 608
Singapore 599
Nanjing 509
Andover 481
Boardman 361
Pellezzano 338
Beijing 281
Düsseldorf 241
Moscow 241
Hebei 178
Fairfield 169
Naples 167
Shenyang 166
Pune 163
Norwalk 162
Mestre 160
Nanchang 157
Changsha 127
Jiaxing 118
Los Angeles 108
Seattle 83
Salerno 80
Tianjin 75
Washington 71
Redwood City 67
Milan 63
Munich 62
São Paulo 58
Ho Chi Minh City 54
New York 54
Council Bluffs 51
San Nicola la Strada 50
Rome 49
Des Moines 46
Nuremberg 46
The Dalles 43
San Diego 41
Hanoi 39
Edinburgh 34
Brooklyn 32
Cambridge 31
Santa Clara 31
Warsaw 30
San Francisco 28
Boston 27
Dearborn 27
Nettuno 27
Rio de Janeiro 27
Chicago 26
Tokyo 26
Belo Horizonte 25
Columbus 24
Sant'Anastasia 23
Jinan 22
Vienna 22
Brussels 20
Florence 19
Shanghai 19
Atlanta 18
Stockholm 18
Montreal 17
Turin 17
Falconara Marittima 16
Guangzhou 16
Ottawa 16
Amsterdam 15
London 15
Venezia 15
Boydton 14
Catania 14
Lappeenranta 14
Turku 14
Baghdad 13
Tashkent 13
Toronto 13
Benevento 12
Brasília 12
Cardito 12
Frankfurt am Main 12
Guayaquil 12
Madrid 12
Paris 12
Wuhan 12
Amman 11
Brescia 11
Casoria 11
Seoul 11
Sofia 11
Totale 36.137
Nome #
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. 1.245
Early traumatic experiences and eating disorders: A focus on the endogenous stress response system 600
Circadian rhythms and treatment implications in depression 445
Assenza di modulazione GABAergica sulla secrezione basale di prolattina e di GH nella schizofrenia cronica 441
No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa 419
Enhanced response of ghrelin to sham feeding in patients with anorexia nervosa 409
Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa 335
Accuracy of self-assessment of real-life functioning in schizophrenia 325
Ghrelin response to hedonic eating in underweight and short-term weight restored patients with anorexia nervosa 317
Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa 297
Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes 233
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects 217
Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa. 209
Physical exercise at night blunts the nocturnal increase of plasma melatonin levels in healthy humans 201
Melanocortin-4 receptor molecular scanning and pro-opiomelanocortin R236G variant screening in binge eating disorder 194
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 188
Appropriatezza clinica, strutturale e operativa nella prevenzione, diagnosi e terapia dei disturbi dell’alimentazione 184
Childhood trauma and cortisol awakening response in symptomatic patients with anorexia nervosa and bulimia nervosa 167
The human pineal gland responds to stress-induced sympathetic activation in the second half of the dark phase: preliminary evidence 159
A 4-year epidemiological study of typical and atypical eating disorders: preliminary evidence for subgroups of atypical eating disorders with different natural outcomes 156
Altered processing of rewarding and aversive basic taste stimuli in symptomatic women with anorexia nervosa and bulimia nervosa: An fMRI study 153
An epidemiological study on eating disorders in two high schools in Naples 152
Lateralization patterns of verbal stimuli processing assessed by reaction time and event-related potentials in schizophrenic patients 145
Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa 144
Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa 142
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa 142
Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-Hydroxytryptamine(2C) receptor involvement 141
3111T/C polymorphism of the clock gene confers a predisposition to a lifetime lower body weight in anorexia and bulimia nervosa 140
Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans 135
Regolazione del comportamento alimentare e correlati biochimici dell’anoressia e bulimia nervosa 134
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder 132
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 131
Serotonin Trasporter Polymorphisms And Ssri Response In Bulimia Nervosa 128
Evidence that cholinergic receptors of muscarinic type may modulate vasopressin release induced by metoclopramide 128
Growth hormone response to GABA?B receptor activation in depressed patients before and after antidepressant therapy 126
Correlations between negative symptoms and peripheral G protein levels in mononuclear leukocytes of deficit and nondeficit schizophrenics. Preliminary results 126
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study. 124
Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa 124
Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine 124
Alterazioni neuroendocrine nella depressione stagionale 124
The treatment of unipolar depression by lithium salts 123
Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder 123
Neuroendocrine effect of short term activation of GABAergic system in schizophrenics with and without tardive dyskinesia 122
The circadian basis of mood disorders: Recent developments and treatment implications 122
Naloxone-induced decrease of plasma prolactin in healthy women 122
Evidence for opiate and estrogen interaction on neurohormonal secretion 122
Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect 122
Chronic antidepressant drug treatment does not affect GH response to baclofen in depressed subjects 122
(+)-N-allylnormetazocine enhances N-acetyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland 121
Combined alpha-adrenergic stimulation results in biphasic response of growth hormone release in man 120
Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia 120
The family of a patient with an eating disorder 120
Underweight subjects with anorexia nervosa have an enhanced salivary cortisol response not seen in weight restored subjects with anorexia nervosa 120
Are antipsychotics useful in the treatment of anorexia nervosa? 119
NEUROENDOCRINOLOGY OF EATING DISORDERS: RECENT ADVANCES AND FUTURE PERSPECTIVES 119
Psychobiology of eating disorders 119
A comparative study of melatonin production in the retina, pineal gland and harderian gland of Bufo viridis and Rana esculenta 119
Brain-derived neurtrophic factor in mood disorders: reply to Kapczinski et al.’s comment 119
The acute salivary ghrelin response to a psychosocial stress is enhanced in symptomatic patients with bulimia nervosa: a pilot study. 117
Effect of pharmacological activation of gamma?aminobutyric acid system on basal pituitary secretion in humans 116
Association between A218C polymorphism of the tryptophan-hydroxylase-1 gene, harm avoidance and binge eating behavior in bulimia nervosa 115
Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa 114
[Evaluation of therapeutic efficacy and pharmacokinetics of controlled release of trazodone in patients with major depressive disorder] 114
Psicobiologia dei disturbi del comportamento alimentare 114
Effects of single and repeated electroconvulsive shock on isoproterenol-stimulated pineal N-acetyltransferase activity and melatonin production in rats 113
Impulsiveness in patients with bulimia nervosa: electrophysiological evidence of reduced inhibitory control. 113
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. 113
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity 113
Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa 112
Self-injurious behavior and attempted suicide in purging bulimia nervosa: Associations with psychiatric comorbidity 112
Circadian Rhythm disturbances in depression: implications for treatment and quality of remission 111
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 111
Risposta della prolattina alla d-fenfluramina in pazienti con sindrome ossessivo-compulsiva prima e dopo terapia con fluvoxamina 111
Association of a functional serotonin transporter gene polymorphism with binge eating disorder 110
Biological background of the psychological effects of cognitive-behavioural therapy in anorexia nervosa 109
Development and validation of the family coping questionnaire for eating disorders 109
Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans 109
PERIPHERAL NEUROSTEROID CONCENTRATIONS IN EATING DISORDERS 109
PLASMA LEPTIN AND WEIGHT GAIN DURINO CLOZAPINE TREATMENT 109
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment 108
Leptin functioning in eating disorders 108
Changes in magnocellular neurosecretory activity following septal forebrain lesions: morphological and biochemical data 107
Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics 107
Brain-derived neurotrophic factor (BDNF) and eating behaviour in bulimia nervosa and binge eating disorder 107
Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients 107
Interhemispheric functional connectivity in anorexia and bulimia nervosa 107
Investigation of the serotonin transporter regulatory region polymorphism in bulimia nervosa: relationships to harm avoidance, nutritional parameters, and psychiatric comorbidity 106
Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects 106
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 106
Immunoendocrine findings in patients with eating disorders 105
INVESTIGATION OF NEUROACTIVE STEROIDS IN ANOREXIA AND BULIMIA NERVOSA 105
Plamsa leptin response to acute fasting and refeeding in untreated women with bulimia nervosa 105
Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorder 105
G-PROTEIN IMMUNOREACTIVITY LEVELS IN LYMPHOCYTES OF DEFICIT AND NONDEFICIT SCHIZOPHRENIC PATIENTS 105
Blunting by chronic phosphatidylserine administration of the stress-induced activation of the hypothalamo-pituitary-adrenal axis in healthy men 105
How do relatives cope with eating disorders? Results from an Italian multicentre study 105
Role of seizure activity in the decreased pineal response to isoproterenol in rats chronically treated with electroconvulsive shock 105
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 104
Psychiatric syndromes in infectious diseases 103
Anoressia e Bulimia Nervosa - NOOS 103
Totale 16.183
Categoria #
all - tutte 163.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.976 0 0 0 21 495 189 462 69 453 30 483 774
2021/20223.332 9 4 18 29 36 22 50 129 517 439 445 1.634
2022/20235.458 616 249 224 479 786 1.162 23 607 737 39 405 131
2023/20242.575 226 332 174 78 153 420 147 241 42 158 201 403
2024/20254.338 328 78 131 148 164 561 610 704 672 194 355 393
2025/20268.061 1.384 2.949 3.484 244 0 0 0 0 0 0 0 0
Totale 48.499